Case 13-2006: A 50-year-old man with a painful bone mass and lesions in the liver

New England Journal of Medicine

Volumn 354, Issue 17, 2006, Pages 1828-1837

  Zhu, Andrew X ^a,c   D'Andrea, Alan D ^b,c   Sahani, Dushyant V ^a,c   Hasserjian, Robert P ^a,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CEFALEXIN; CISPLATIN; CONTRAST MEDIUM; DOXORUBICIN; ERYTHROMYCIN; ERYTHROPOIETIN; ETHIODIZED OIL; IODINATED CONTRAST MEDIUM; MITOMYCIN; PARACETAMOL; PREDNISONE; RECOMBINANT ERYTHROPOIETIN; ROFECOXIB; ZOLEDRONIC ACID; ZOLPIDEM;

ADULT; ANAMNESIS; ARTICLE; BLOOD ANALYSIS; BONE LESION; BONE MASS; BONE METASTASIS; BONE PAIN; CANCER RADIOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE EXACERBATION; DNA DAMAGE; DNA REPAIR; DRUG FEVER; ERYTHROPENIA; FANCONI ANEMIA; HUMAN; JOINT STIFFNESS; LABORATORY TEST; LIVER CELL CARCINOMA; LIVER FUNCTION TEST; LIVER INJURY; MALE; PAIN ASSESSMENT; PANCYTOPENIA; PHYSICIAN; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROTEIN ELECTROPHORESIS; SEPSIS; ULNA; BONE DISEASE; BONE TUMOR; CLINICAL OBSERVATION; CLINICAL STUDY; DIAGNOSIS; ELBOW; ESOPHAGUS TUMOR; FATALITY; LIVER; LIVER TUMOR; METASTASIS; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY; SQUAMOUS CELL CARCINOMA;

BONE DISEASES; BONE NEOPLASMS; CARCINOMA, HEPATOCELLULAR; CARCINOMA, SQUAMOUS CELL; DIAGNOSIS, DIFFERENTIAL; ELBOW; ESOPHAGEAL NEOPLASMS; FANCONI ANEMIA; FATAL OUTCOME; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; PANCYTOPENIA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33646113138     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcpc069004     Document Type: Article

References (27)

1. Kennedy RD, D'Andrea AD. The Fanconi anemia/BRCA pathway: new faces in the crowd. Genes Dev 2005;19:2925-40.
2. Auerbach AD. Fanconi anemia diagnosis and the diepoxybutane (DEB) test. Exp Hematol 1993;21:731-3.
3. Levitus M, Rooimans MA, Steltenpool J, et al. Heterogeneity in Fanconi anemia: evidence for 2 new genetic subtypes. Blood 2004;103:2498-503.
4. Meetei AR, Levitus M, Xue Y, et al. X-linked inheritance of Fanconi anemia complementation group B. Nat Genet 2004;36:1219-24.
5. Howlett NG, Taniguchi T, Olson S, et al. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 2002;297:606-9.
6. Alter BP, Greene MH, Velazquez I, Rosenberg PS. Cancer in Fanconi anemia. Blood 2003;101:2072.
7. Shimamura A, D'Andrea AD. Subtyping of Fanconi anemia patients. Blood 2003;102:3459.
8. Lo Ten Foe JR, Kwee ML, Rooimans MA, et al. Somatic mosaicism in Fanconi anemia: molecular basis and clinical significance. Eur J Hum Genet 1997;5:137-48.
9. Alter BP. Cancer in Fanconi anemia, 1927-2001. Cancer 2003;97:425-40.
10. Rosenberg PS, Greene MH, Alter BP. Cancer incidence in persons with Fanconi anemia. Blood 2003;101:822-6. [Erratum, Blood 2003;101:2136.]
11. Kutler DI, Singh B, Satagopan J, et al. A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood 2003;101:1249-56.
12. Deeg HJ, Socie G, Schoch G, et al. Malignancies after marrow transplantation for aplastic anemia and Fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients. Blood 1996;87:386-92.
13. Rosenberg PS, Socie G, Alter BP, Gluckman E. Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants. Blood 2005;105:67-73.
14. Cassinat B, Guardiola P, Chevret S, et al. Constitutive elevation of serum alpha-fetoprotein in Fanconi anemia. Blood 2000;96:859-63.
15. Handin RI, Lux SE, Stossel TP, eds. Blood: principles and practice of hematology. Philadelphia: J.B. Lippincott, 1995:233.
16. Alter BP. Fetal erythropoiesis in stress hematopoiesis. Exp Hematol 1979;7:Suppl 5:200-9.
17. Dell'Orbo C, Arico M, Podesta A, Bianchi E. Fanconi's anemia: ultrastructural observations on erythroblasts. Ultrastruct Pathol 1983;4:145-50.
18. Alter BP, Caruso JP, Drachtman RA, Uchida T, Velagaleti GV, Elghetany MT. Fanconi's anemia: myelodysplasia as a predictor of outcome. Cancer Genet Cytogenet 2000;117:125-31.
19. Auerbach AD, Allen RG. Leukemia and preleukemia in Fanconi anemia patients: a review of the literature and report of the International Fanconi Anemia Registry. Cancer Genet Cytogenet 1991;51:1-12.
20. Butturini A, Gale RP, Verlander PC, Adler-Brecher B, Gillio AP, Auerbach AD. Hematologic abnormalities in Fanconi anemia: an International Fanconi Anemia Registry study. Blood 1994;84:1650-5.
21. Chu P, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol 2000;13:962-72.
22. A free immunoquery database is made available as a Website. Int J Surg Pathol 2000;8:4.
23. Gattuso P, Reyes CV. Hepatocellular carcinoma with bone metastasis. J Surg Oncol 1988;39:33-4.
24. Kakar S, Muir T, Murphy LM, Lloyd RV, Burgart LJ. Immunoreactivity of Hep Par 1 in hepatic and extrahepatic tumors and its correlation with albumin in situ hybridization in hepatocellular carcinoma. Am J Clin Pathol 2003;119:361-6.
25. Wieczorek TJ, Pinkus JL, Glickman JN, Pinkus GS. Comparison of thyroid transcription factor-1 and hepatocyte antigen immunohistochemical analysis in the differential diagnosis of hepatocellular carcinoma, metastatic adenocarcinoma, renal cell carcinoma, and adrenal cortical carcinoma. Am J Clin Pathol 2002;118:911-21.
26. Llovet JM, Real MI, Montana X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002;359:1734-9.
27. Lo CM, Ngan H, Tso WK, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002;35:1164-71.